Category Specific RSS

CXCL10

CLEO meets with US FDA to develop strategy for ovarian cancer test launch

Ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV) has taken a major step towards the US launch of its pre-surgical…

1 year ago

IPO Watch: Cleo Diagnostics to go public with ovarian cancer test kits to address 51% survival rate

As diseases continue to adapt, the realm of medical diagnostics must intelligently progress to adeptly combat these changes. Timely interventions…

2 years ago